Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit

Epilepsia

Volumn 46, Issue 6, 2005, Pages 949-951

  Boggs, Jane G ^a,c   Preis, Keith ^b  

^a ORLANDO HEALTH   (United States)

^b Neurological Associates of Ocean County   (United States)

^c Epilepsy Services   (United States)

Author keywords

Divalproex sodium extended; EMU; Epilepsy; Release tablets; Tolerability; Treatment; Valproate sodium injection

Indexed keywords

VALPROATE SEMISODIUM; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DIZZINESS; DOSE RESPONSE; DRUG TOLERABILITY; EPILEPSY; FEMALE; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; SEIZURE; SUSTAINED DRUG RELEASE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DELAYED-ACTION PREPARATIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL UNITS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VALPROIC ACID;

EID: 20544465309     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2005.69703.x     Document Type: Article

References (12)

1. Scott CA, Fish TR, Allen PJ. Design of an intensive epilepsy monitoring unit. Epilepsia 2000;41(suppl 5):S3-8.
2. Venkataraman V, Wheless JW. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res 1999;35:147-53.
3. Limdi NA, Faught E. The safety of rapid valproic acid infusion. Epilepsia 2000;41:1342-5.
4. Ramsay RE, Cantrell D, Collins SD, et al. Safety and tolerance of rapidly infused Depacon: a randomized trial in subjects with epilepsy. Epilepsy Res 2003;52:189-201.
5. Dutta S, Zhang Y, Selness DS, et al. Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers. Epilepsy Res 2002;49:1-10.
6. Freitag FG, Collins SD, Carlson HA, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 2002;58:1652-9.
7. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 2000;55:722-4.
8. Dutta S, Cloyd JC, Granneman GR, et al. Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation. Epilepsy Res 2003;53:29-38.
9. Gilliam FG. Status epilepticus. In: Wyllie E, ed. The treatment of epilepsy: principles and practice. Baltimore: Williams & Wilkins, 1996:666-76.
10. Cranford RE, Leppik IE, Patrick B, et al. Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 1978;28:874-80.
11. Gal P, Tobock J, Boes H, et al. Efficacy of phenobarbital monotherapy in treatment of neonatal seizures: relationship to blood levels. Neurology 1982;32:1401-4.
12. Thibault M, Blume WT, Saint-Hilaire JM, et al. Divalproex extended-release vs. the original divalproex tablet: results of a randomized, crossover study of well-controlled epileptic patients with primary generalized seizures. Epilepsy Res 2002;50:243-9.